Stock FMS FRESENIUS MEDICAL CARE AG
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Fresenius Medical Care AG Nyse

Equities

FMS

US3580291066

Market Closed - Nyse
Other stock markets
 04:00:02 2024-04-29 pm EDT 		Pre-market 09:26:46 am
20.71 USD +3.03% Intraday chart for Fresenius Medical Care AG 20.92 +0.99%
Apr. 29 European Equities Traded in the US as American Depositary Receipts Nudge Higher in Monday Trading MT
Apr. 26 FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Gets a Sell rating from Jefferies ZD

Strengths

  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • Given the positive cash flows generated by its business, the company's valuation level is an asset.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The company is in debt and has limited leeway for investment
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-0.58% 12.15B -
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.58% 85.02B
B-
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+15.05% 82.37B
C+
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.49% 29.29B
C+
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-10.17% 17.21B
B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.64% 16.7B
A-
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+1.17% 15.5B
A-
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.71% 12.13B
A-
DAVITA INC. Stock DaVita Inc.
+31.86% 12.12B
B-
PURE HEALTH HOLDING Stock Pure Health Holding
-31.05% 11.8B - -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. FME Stock
  4. FMS Stock
  5. Ratings Fresenius Medical Care AG